Company intelligence / Profile preview

DiproBio

Shanghai, Shanghai, Chinadiprobio.com ↗

Ownership: Private
Development stage: Other

Overview

DiproBio is recognized as a leading provider of microecological health medical solutions in China. The company has developed one of the largest native probiotic strain banks in China and offers individualized precision nutrition and health management solutions based on advanced microbiology research. It holds dozens of patents related to probiotic products and has launched multiple innovative products addressing diverse consumer needs

Therapeutic areas: GastroenterologyMetabolic Disorders
Modalities: Live biotherapeutic product therapyMicrobial therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on DiproBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DiproBio.

Explore the full profile